7. Device Update


Apps linked with FreeStyle Libre: LibreLink, LibreLinkUp & LibreView

FDA approves Proclaimâ„¢ XR SCS system for diabetic neuropathy

      The FreeStyle Libre app is designed for individuals with diabetes to conduct routine glucose monitoring using a smartphone and a FreeStyle Libre sensor. The app offers an insightful eight-hour glucose history and provides a directional arrow, indicating the trajectory of glucose changes. Moreover, the FreeStyle LibreLink app incorporates an array of in-app reports, effectively visualizing trends, and patterns to enhance users' understanding of their glucose control. Through this convenient technology, users can forgo the hassle of frequent finger pricks, obtaining their sugar readings with a swift 1-second scan. Notably, the app requires NFC and Bluetooth connectivity and is compatible with specific mobile devices and operating systems. Key features include Daily Patterns, showcasing the variability of sensor glucose readings over a typical day, and Time in Range, which displays the percentage of time glucose readings were above, below, or within the Target Glucose Range.

      The LibreLinkUp app is intended for use by family, friends, and caregivers, providing 12-hour glucose graphs and alarms. It supports up to 20 individuals from a single LibreLinkUp account. However, it is not meant to serve as the primary glucose monitor. Therefore, users should consult their primary device(s) and a healthcare professional before making any medical interpretations or adjustments based on the app's information. This device is not meant to replace self-monitoring practices as advised by a physician.

      LibreView is a secure, cloud-based diabetes management system that offers healthcare professionals and patients clear, comprehensible reports from compatible FreeStyle glucose monitoring devices. It provides a consistent set of clear, intuitive reports that facilitate the discovery of patterns and trends quickly and easily. The system's ability to share reports remotely with internet connectivity from anywhere is another advantage. The report from LibreView includes a summary of glucose, meter usage, and insulin data for a 14-day period, along with comments highlighting important glucose trends.


This newsletter is published for free distribution through the Internet for doctors, patients and public for promoting healthy lifestyles.
For enquiries info@jothydev.net.
Please visit: jothydev.net | research.jothydev.com | diabscreenkerala.net | jothydev.com/newsletter